… , sarcopenia predicted not only the onset of exacerbations … in the sarcopenia group
can be attributed to ILD exacerbation. … exacerbation and prognosis in patients with ILD-complicated …

… exacerbation (AE) of interstitial lung disease caused by … that most toxic effects are thought to
be caused by direct … max of contralateral interstitial lesions on 18F-FDG PET/CT, sarcopenia, …

… may suggest ongoing muscle loss, which may be caused by … than chemotherapy among
sarcopenic patients with lung … of the impact sarcopenia has on patients with lung cancer with a …

… the impact of sarcopenia on erlotinib therapy and prognosis in patients with EGFR-mutated
(exon 19 or 21 L858R) metastatic lung … with NSCLC receiving chemotherapy. In this study, …

… | Clinical impact of sarcopenia on chemotherapy-triggered … association with
chemotherapy-triggered ILD exacerbations has yet … whether sarcopenia could predict ILD …

… metabolism abnormalities caused by sarcopenia may reduce … damage and inflammatory
reactions, exacerbating the severity of … can affect the efficacy of chemotherapy combined with …

… the calculation of chemotherapy dosage [21]. The effects of sarcopenia have been extensively
… patients is thought to be caused by hypercatabolic state and inflammation with increased …

… syndromes, which are mainly caused by the production of … to sarcopenia and muscle
dysfunction in patients with lung … protein intake in patients undergoing chemotherapy (166). The …

… function, primarily caused by malnutrition, chronic diseases, and cancer (… chemotherapy
and concluded that sarcopenia group had a higher rate of interstitial lung disease exacerbation, …